IPO Outlook For The Week: Beauty Treatments, Banking and Liver Therapy


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed.

AMTD International Inc. (KHIB) will issue nearly 20.8 million shares between $8.10 and $8.48 Monday on the New York Stock Exchange. The offering represents 100% of outstanding shares and is expected to raise about $202.4 million. The Hong-Kong financial company provides investment banking and asset management services in Asia and the U.S.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Biovie Inc. (OTC:BIVI) will issue nearly 1.3 million shares at $11.88 Wednesday on the Nasdaq. The offering represents 23.7% of outstanding shares and is expected to raise more than $17.2 million. Based in Los Angeles, the clinical-stage biotech company develops therapies for ascites caused by liver cirrhosis.

Inmode Ltd. (INMD) will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 15.6% of outstanding shares and is expected to raise $92 million. The California medtech company markets technology to accompany beauty treatments, including hair removal and plastic surgery.

Related Links:

What Is Reg A+?

What Is A Lock-Up Expiration Date And Why Is It Important?


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsPreviewsIPOsTop StoriesTrading Ideas